HUTCHMED (China) HMDCF
NASDAQ HMDCF
$2.16 +0.00 (+0.00%)
At close: Sep 8, 2026 · 4:00 PM EDT

HUTCHMED (China) (HMDCF) Prepaid Assets (2015 - 2026)

HUTCHMED (China)'s (HMDCF) quarterly Prepaid Assets came in at $11.0 million in Q2 2026, down 5.23% year-over-year from $11.6 million in Q2 2025, and up 31.33% quarter-over-quarter from $8.3 million in Q4 2025.

Analysis

HUTCHMED (China) (HMDCF) Prepaid Assets (2015 - 2026) Analysis & Trends

HUTCHMED (China) (HMDCF) has reported Prepaid Assets for 11 consecutive years, with $11.0 million the latest figure, recorded in Q2 2026.

  • On a quarterly basis, Prepaid Assets fell 5.23% year-over-year to $11.0 million in Q2 2026; TTM through Jun 2026 was $11.0 million, a 5.23% decrease from a year earlier, with the FY2025 full-year figure at $8.3 million, down 88.87% from the prior year.
  • Prepaid Assets was $11.0 million for Q2 2026 at HUTCHMED (China), up from $8.3 million in the prior quarter.
  • Over five years, Prepaid Assets peaked at $110.9 million in Q4 2022 and troughed at $7.1 million in Q2 2024.
  • A 5-year average of $38.8 million and a median of $12.1 million in 2023 frame the typical range for Prepaid Assets.
  • The widest YoY moves for Prepaid Assets: up 63.17% in 2025, down 88.87% in 2025.
  • Over 5 years, Prepaid Assets stood at $110.9 million in 2022, then decreased by 15.59% to $93.6 million in 2023, then dropped by 19.98% to $74.9 million in 2024, then plunged by 88.87% to $8.3 million in 2025, then soared by 31.33% to $11.0 million in 2026.
  • The last three Prepaid Assets figures came in at $11.0 million (Q2 2026), $8.3 million (Q4 2025), and $11.6 million (Q2 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Amgen 210.97 Bn 196.98 Bn 7.24 Bn
2 Gilead Sciences 180.98 Bn 177.80 Bn 6.22 Bn
3 Vertex Pharmaceuticals 132.09 Bn 124.24 Bn 2.84 Bn
4 Regeneron Pharmaceuticals 82.56 Bn 74.57 Bn 3.93 Bn
5 Argenx Se 61.71 Bn 56.53 Bn 1.37 Bn
6 Moderna 54.60 Bn 49.46 Bn 52.00 Mn
7 Alnylam Pharmaceuticals 34.02 Bn 30.71 Bn 992.69 Mn
8 Biogen 31.25 Bn 29.97 Bn 1.96 Bn
9 Roivant Sciences 29.76 Bn 29.76 Bn 1.16 Mn
10 HUTCHMED (China) 376.85 Mn 391.04 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 10.95 Mn
Dec 31, 2025 8.34 Mn
Jun 30, 2025 11.56 Mn
Dec 31, 2024 74.91 Mn
Jun 30, 2024 7.08 Mn
Dec 31, 2023 93.61 Mn
Jun 30, 2023 12.05 Mn
Dec 31, 2022 110.90 Mn
Jun 30, 2022 19.89 Mn
Mar 31, 2021 27.27 Mn
Dec 31, 2019 56.60 Mn
Sep 30, 2019 19.52 Mn
Jun 30, 2019 15.23 Mn
Mar 31, 2019 18.25 Mn
Dec 31, 2018 4.25 Mn
Jun 30, 2018 4.96 Mn
Dec 31, 2017 2.57 Mn
Jun 30, 2017 1.07 Mn
Dec 31, 2016 699,000.00
Dec 31, 2015 19,000.00